相关实验视频
Updated: Feb 20, 2026

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
1.1K
胸内血管大动脉修复 (TEVAR) 后心力衰竭率
Amalia I Moula1, Konstantinos Spanos2, Andrew Xanthopoulos3
1Department of Surgery, "Achillopouleion" General Hospital, Volos, Greece.
概括
胸内血管大动脉修复 (TEVAR) 可能导致心力衰竭 (HF) 在30天内. 这种并发症发生在约3%的患者中,与大动脉硬和血流变化有关,需要仔细监测和潜在的早期干预.
科学领域:
- 心血管外科心血管外科
- 医疗器械 医疗器械
- 临床结果 临床结果
背景情况:
- 胸内血管大动脉修复 (TEVAR) 是对胸大动脉动脉瘤 (TAA) 的微创治疗方法.
- TEVAR对胸前大动脉血动力学和潜在的心力衰竭 (HF) 诱导的影响仍然令人担忧.
- 造形后血液流量的改变可能导致高血压和冠状动脉输液减少,可能导致高血压.
研究的目的:
- 为了调查胸内血管大动脉修复 (TEVAR) 后心力衰竭 (HF) 的发生率.
- 分析TEVAR诱导的血液动力学变化与HF发展之间的潜在关联.
- 为提供临床洞察力,了解HF作为TEVAR的并发症.
主要方法:
- 在PubMed,Web of Science,Scopus和Cochrane图书馆进行了系统的文献搜索.
- 十一项研究符合元分析的纳入标准.
- 主要终点是TEVAR后30天内HF的原始发病率.
主要成果:
- 分析包括30680名患者,其中684人在TEVAR后30天内发展HF (2.23%).
- 汇总的HF发病率为0.03 (95% CI [0.02-0.04]),观察到显著的异质性 (I2=99.999%) 和出版偏差.
- HF的发生可能归因于大动脉硬度增加和随后的血液动力学变化减少冠状动脉血液供应.
结论:
- 心力衰竭是一个临床相关的,虽然经常被忽视的并发症,在TEVAR治疗后30天内发生在约3%的患者中.
- 在TEVAR后,大动脉硬度增加和血液动力学变化可能会导致HF的发展.
- 建议早期药理干预和血液动力学优化,以及仔细的心脏监测,特别是在高风险患者中. 进一步的RCT是有必要的.
相关概念视频
Aneurysm III: Interprofessional Care
338
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
338
Aortic Regurgitation III: Medical Management
479
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
479
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
626
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
626
Aortic Regurgitation I: Introduction
789
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
789

